MYLAN
VTRSViatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Drugs in Pipeline
89
Phase 3 Programs
78
Upcoming Catalysts
6
Next Catalyst
Aug 6, 2026
TomorrowMarket Overview
Stock performance and key metrics
7 upcoming, 1 past
VTRS Earnings Report
EPS Est: $0.62 | FQ end 2026-06 | Call: 2026-08-06 15:00:00
6 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How VTRS's past catalysts played out
MYL-1701P
Diabetic Macular Edema
Amlodipine/atorvastatin single pill
Hypertension
MYL-1601D Product
Diabetes Mellitus, Type 1
venlafaxine ER 75 mg/day (fixed dose)
Major Depressive Disorder
Risperidone
Schizophrenia
LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION
Glaucoma, Primary Open Angle (POAG)
Revefenacin
Chronic Obstructive Pulmonary Disease, COPD
sildenafil
Sexual Dysfunctions, Psychological
i. Fixed combination of latanoprost 0.005% and timolol 0.5%
Ocular Hypertension
MYL-1401H
Breast Neoplasms
latanoprost
Glaucoma
tramadol HCL
Low Back Pain
Formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Diclofenac SR
Ankylosing Spondylitis
pramipexol
Idiopathic Restless Legs Syndrome
Sumatriptan 25 mg
Migraine With or Without Aura
MYL- 1401O
Breast Cancer
ziprasidone versus olanzapine , risperidone or quetiapine
Schizophrenia
Econazole Nitrate Cream, 1%
Tinea Pedis
Eletriptan 20 mg
Migraine With or Without Aura
Eletriptan 80 mg
Migraine With or Without Aura
pramipexole
Restless Legs Syndrome
Diclofenac sodium gel 1%
Osteoarthritis, Knee
tolterodine extended release capsule
Urinary Incontinence
iv sildenafil
Pulmonary Hypertension, Familial Persistent, of the Newborn
olanzapine
Schizophrenia
Venlafaxine ER
Major Depressive Disorder
Venlafaxine XR
Anxiety
Xalacom
Glaucoma, Open Angle
Mylan's insulin glargine
Type 1 Diabetes
Lantus®
Type 2 Diabetes
MYL-1701P, a proposed biosimilar to Eylea
Diabetic Macular Edema
Pimecrolimus Cream, 1%
Atopic Dermatitis
Ziprasidone
Schizophrenia
Gabapentin
Transient Insomnia
Sildenafil citrate
Pulmonary Arterial Hypertension, Children
Transdermal system containing progestin
Female Contraception
MYL-1501D product using manufacture process V
Diabetes Mellitus, Type 1
Eletriptan HBr 40 mg
Migraine Without Aura
Eplerenone
Heart Failure
sildenafil citrate (UK-92,480)
Pulmonary Hypertension
Geodon (Ziprasidone)
Bipolar Disorder
pregabalin (Lyrica)
Diabetic Neuropathy, Painful
Xalatan
Glaucoma, Open-Angle
Diphenhydramine citrate
Healthy
Indomethacin
Arthritis, Gouty
Atorvastatin calcium 10 mg
Hypercholesterolemia
Ziprasidone Oral Capsule
Bipolar Mania
Pregabalin Dose Level 1
Partial Onset Seizures
Intramuscular ziprasidone mesylate
Schizophrenia
Nebivolol
Hypertension
Revefenacin 175 mcg in 3 ML Inhalation Solution
COPD
Timolol
Open Angle Glaucoma
Amlodipine
Hypertension
Amlodipine/Atorvastatin
Hypertension
Pregabalin Dose Level 2
Generalized Tonic Clonic Seizures
pregabalin
Generalized Anxiety Disorder
Clozapine
Schizophrenia
Estradiol Vaginal Cream, 0.01%
Atrophic Vaginitis
Eletriptan 40 mg
Migraine With or Without Aura
Nebivolol and Atenolol
Hypertension
TD-4208
Chronic Obstructive Pulmonary Disease (COPD)
Amlodipine 2.5mg/Atorvastatin 5mg
Hypertension
latanoprost 0.005%
Ocular Hypertension
celecoxib and ibuprofen SR
Pain, Postoperative
Lamotrigine
Epilepsy, Partial
MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
Asthma
Ziprasidone oral capsules
Bipolar Disorder
atorvastatin
Familial Hypercholesterolemia
apomorphine HCl injection
Parkinson Disease
PhXA41
Open Angle Glaucoma
Celecoxib
Low Back Pain
Tiotropium
Chronic Obstructive Pulmonary Disease (COPD)
Pregabalin add-on therapy
Epilepsy, Partial Seizures
MR-100A-01
Contraception
MYL-1401A (Adalimumab)
Psoriasis
Nebivolol (NEB)
Hypertension
levetiracetam
Partial Seizures
sertraline/[S,S]-reboxetine
Depressive Disorder, Major
MR-107A-02
Acute Pain
latanoprost 75 ug
Primary Open Angle Glaucoma
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)
Contraception
TD-4208 700 μg
Chronic Obstructive Pulmonary Disease, COPD
MR-107A-01
Pain
Cysteamine
HIV Infections
Alprazolam
Dental Anxiety
Sildenafil 100 mg
Female Sexual Arousal Disorder
Permethrin Foam 4%
Scabies
MR-130A-01 Transdermal patch
Contraception
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
MYL-1701P | Phase 3 | Diabetic Macular Edema | - | - |
Amlodipine/atorvastatin single pill | Phase 3 | Hypertension | - | - |
MYL-1601D Product | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
venlafaxine ER 75 mg/day (fixed dose) | Phase 3 | Major Depressive Disorder | - | - |
Risperidone | Phase 3 | Schizophrenia | - | - |
LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION | Phase 3 | Glaucoma, Primary Open Angle (POAG) | - | - |
Revefenacin | Phase 3 | Chronic Obstructive Pulmonary Disease, COPD | - | - |
sildenafil | Phase 3 | Sexual Dysfunctions, Psychological | - | - |
i. Fixed combination of latanoprost 0.005% and timolol 0.5% | Phase 3 | Ocular Hypertension | - | - |
MYL-1401H | Phase 3 | Breast Neoplasms | - | - |
latanoprost | Phase 3 | Glaucoma | - | - |
tramadol HCL | Phase 3 | Low Back Pain | - | - |
Formoterol | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Diclofenac SR | Phase 3 | Ankylosing Spondylitis | - | - |
pramipexol | Phase 3 | Idiopathic Restless Legs Syndrome | - | - |
Sumatriptan 25 mg | Phase 3 | Migraine With or Without Aura | - | - |
MYL- 1401O | Phase 3 | Breast Cancer | - | - |
ziprasidone versus olanzapine , risperidone or quetiapine | Phase 3 | Schizophrenia | - | - |
Econazole Nitrate Cream, 1% | Phase 3 | Tinea Pedis | - | - |
Eletriptan 20 mg | Phase 3 | Migraine With or Without Aura | - | - |
Eletriptan 80 mg | Phase 3 | Migraine With or Without Aura | - | - |
pramipexole | Phase 3 | Restless Legs Syndrome | - | - |
Diclofenac sodium gel 1% | Phase 3 | Osteoarthritis, Knee | - | - |
tolterodine extended release capsule | Phase 3 | Urinary Incontinence | - | - |
iv sildenafil | Phase 3 | Pulmonary Hypertension, Familial Persistent, of the Newborn | - | - |
olanzapine | Phase 3 | Schizophrenia | - | - |
Venlafaxine ER | Phase 3 | Major Depressive Disorder | - | - |
Venlafaxine XR | Phase 3 | Anxiety | - | - |
Xalacom | Phase 3 | Glaucoma, Open Angle | - | - |
Mylan's insulin glargine | Phase 3 | Type 1 Diabetes | - | - |
Lantus® | Phase 3 | Type 2 Diabetes | - | - |
MYL-1701P, a proposed biosimilar to Eylea | Phase 3 | Diabetic Macular Edema | - | - |
Pimecrolimus Cream, 1% | Phase 3 | Atopic Dermatitis | - | - |
Ziprasidone | Phase 3 | Schizophrenia | - | - |
Gabapentin | Phase 3 | Transient Insomnia | - | - |
Sildenafil citrate | Phase 3 | Pulmonary Arterial Hypertension, Children | - | - |
Transdermal system containing progestin | Phase 3 | Female Contraception | - | - |
MYL-1501D product using manufacture process V | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
Eletriptan HBr 40 mg | Phase 3 | Migraine Without Aura | - | - |
Eplerenone | Phase 3 | Heart Failure | - | - |
sildenafil citrate (UK-92,480) | Phase 3 | Pulmonary Hypertension | - | - |
Geodon (Ziprasidone) | Phase 3 | Bipolar Disorder | - | - |
pregabalin (Lyrica) | Phase 3 | Diabetic Neuropathy, Painful | - | - |
Xalatan | Phase 3 | Glaucoma, Open-Angle | - | - |
Diphenhydramine citrate | Phase 3 | Healthy | - | - |
Indomethacin | Phase 3 | Arthritis, Gouty | - | - |
Atorvastatin calcium 10 mg | Phase 3 | Hypercholesterolemia | - | - |
Ziprasidone Oral Capsule | Phase 3 | Bipolar Mania | - | - |
Pregabalin Dose Level 1 | Phase 3 | Partial Onset Seizures | - | - |
Intramuscular ziprasidone mesylate | Phase 3 | Schizophrenia | - | - |
Nebivolol | Phase 3 | Hypertension | - | - |
Revefenacin 175 mcg in 3 ML Inhalation Solution | Phase 3 | COPD | - | - |
Timolol | Phase 3 | Open Angle Glaucoma | - | - |
Amlodipine | Phase 3 | Hypertension | - | - |
Amlodipine/Atorvastatin | Phase 3 | Hypertension | - | - |
Pregabalin Dose Level 2 | Phase 3 | Generalized Tonic Clonic Seizures | - | - |
pregabalin | Phase 3 | Generalized Anxiety Disorder | - | - |
Clozapine | Phase 3 | Schizophrenia | - | - |
Estradiol Vaginal Cream, 0.01% | Phase 3 | Atrophic Vaginitis | - | - |
Eletriptan 40 mg | Phase 3 | Migraine With or Without Aura | - | - |
Nebivolol and Atenolol | Phase 3 | Hypertension | - | - |
TD-4208 | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Amlodipine 2.5mg/Atorvastatin 5mg | Phase 3 | Hypertension | - | - |
latanoprost 0.005% | Phase 3 | Ocular Hypertension | - | - |
celecoxib and ibuprofen SR | Phase 3 | Pain, Postoperative | - | - |
Lamotrigine | Phase 3 | Epilepsy, Partial | - | - |
MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate) | Phase 3 | Asthma | - | - |
Ziprasidone oral capsules | Phase 3 | Bipolar Disorder | - | - |
atorvastatin | Phase 3 | Familial Hypercholesterolemia | - | - |
apomorphine HCl injection | Phase 3 | Parkinson Disease | - | - |
PhXA41 | Phase 3 | Open Angle Glaucoma | - | - |
Celecoxib | Phase 3 | Low Back Pain | - | - |
Tiotropium | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Pregabalin add-on therapy | Phase 3 | Epilepsy, Partial Seizures | - | - |
MR-100A-01 | Phase 3 | Contraception | - | - |
MYL-1401A (Adalimumab) | Phase 3 | Psoriasis | - | - |
Nebivolol (NEB) | Phase 3 | Hypertension | - | - |
levetiracetam | Phase 3 | Partial Seizures | - | - |
sertraline/[S,S]-reboxetine | Phase 2 | Depressive Disorder, Major | - | - |
MR-107A-02 | Phase 2 | Acute Pain | - | - |
latanoprost 75 ug | Phase 2 | Primary Open Angle Glaucoma | - | - |
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN) | Phase 2 | Contraception | - | - |
TD-4208 700 μg | Phase 2 | Chronic Obstructive Pulmonary Disease, COPD | - | - |
MR-107A-01 | Phase 2 | Pain | - | - |
Cysteamine | Phase 2 | HIV Infections | - | - |
Alprazolam | Phase 2 | Dental Anxiety | - | - |
Sildenafil 100 mg | Phase 2 | Female Sexual Arousal Disorder | - | - |
Permethrin Foam 4% | Phase 2 | Scabies | - | - |
MR-130A-01 Transdermal patch | Phase 2 | Contraception | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in MYLAN's drug pipeline?→
CatalystAlert tracks 89 drug candidates in MYLAN's (VTRS) pipeline across Phase 3, Phase 2. Its lead program is MYL-1701P (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MYLAN's next FDA catalyst?→
MYLAN's (VTRS) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VTRS biotech catalysts?→
Add VTRS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MYLAN's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.